[Neuraminidase induced hemolytic anemia. Experimental and clinical observations (author's transl)]
- PMID: 1246237
[Neuraminidase induced hemolytic anemia. Experimental and clinical observations (author's transl)]
Abstract
Recently, increasing attention has been focussed on the in vivo action of neuraminidase as possible pathogenetical factor of hemolytic anemia and even hemolytic-uremic syndrome. Neuraminidase action in red cell membranes results in the release of neuraminic acid, and thereby the uncovering of previously hidden receptors, socalled cryptantigens. With special reference to the phythemagglutinin Anti-TAh from the peanut (Arachis hypogae) and the agglutinin Anti-AHP from the albumin gland of the small Helix pomatia we describe some new methods for the detection of these cryptantigens. In addition to the screebubg genagglutination test with Anti-TAh we developed an "Anti-T-consumption test" for quantitative detection of neuraminidase action on red cells. With the purified reagents we developed an indirect fluorescnet antibody method on blood smears for the detection of cryptantigens on single cells. By animal experiments we could show that not only the membranes of red cells but the intima of renal capillaries as well are damaged by neuraminidase. With these new methods we observed 14 patients suffering from hemolytic anemia due to bacterial or viral neuraminidase. Some of these patients developed a hemolytic-uremic syndrome. We believe that the positive reaction with Anti-T Ah should lead to prophylactic heparinization to prevent dissiminated intravascular coagulation. Neuraminidase is the first identified toxin which directly acts on the membranes of red cells and the intima of renal capillaries as well, and thereby in some patients may induce hemolytic-uremic syndrome. Possibly, these results may stimulate the development of further testsystems for the detection of still unknown toxins which are not tested with our reagents, but may equally be involved in the damage of cell membranes.
Similar articles
-
[Neuraminidase-producing pneumococci in the pathogenesis of hemolytic-uremic syndrome].Schweiz Med Wochenschr. 1980 Oct 4;110(40):1454-6. Schweiz Med Wochenschr. 1980. PMID: 7280595 German.
-
Red blood cell Thomsen-Friedenreich antigen expression and galectin-3 plasma concentrations in Streptococcus pneumoniae-associated hemolytic uremic syndrome and hemolytic anemia.Transfusion. 2015 Jun;55(6 Pt 2):1563-71. doi: 10.1111/trf.12981. Epub 2014 Dec 30. Transfusion. 2015. PMID: 25556575
-
Prophylactic heparinization is ineffective in a primate model of hemolytic uremic syndrome.Pediatr Nephrol. 2002 Dec;17(12):1053-8. doi: 10.1007/s00467-002-1002-3. Epub 2002 Nov 8. Pediatr Nephrol. 2002. PMID: 12478357
-
[Uraemic-haemolytic syndrome (author's transl)].Sangre (Barc). 1980;25(5B):760-73. Sangre (Barc). 1980. PMID: 7008224 Review. Spanish. No abstract available.
-
Update on Streptococcus pneumoniae associated hemolytic uremic syndrome.Curr Opin Pediatr. 2013 Apr;25(2):203-8. doi: 10.1097/MOP.0b013e32835d7f2c. Curr Opin Pediatr. 2013. PMID: 23481474 Review.
Cited by
-
The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.Biomolecules. 2023 Dec 27;14(1):39. doi: 10.3390/biom14010039. Biomolecules. 2023. PMID: 38254639 Free PMC article. Review.
-
Red blood cell T-activation and hemolysis in surgical intensive care patients with severe infections.Blut. 1987 Feb;54(2):89-96. doi: 10.1007/BF00321036. Blut. 1987. PMID: 3814829
-
Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic-uremic syndrome).Klin Wochenschr. 1980 Feb 15;58(4):173-84. doi: 10.1007/BF01476776. Klin Wochenschr. 1980. PMID: 7382329 No abstract available.
-
Monoclonal antibodies for the detection of desialylation of erythrocyte membranes during haemolytic disease and haemolytic uraemic syndrome caused by the in vivo action of microbial neuraminidase.Glycoconj J. 1997 Sep;14(6):699-706. doi: 10.1023/a:1018565316310. Glycoconj J. 1997. PMID: 9337082
-
[Clinical aspects of the hemolytic-uremic syndrome].Klin Wochenschr. 1979 Oct 1;57(19):1081-4. doi: 10.1007/BF01479994. Klin Wochenschr. 1979. PMID: 392182 Review. German. No abstract available.